(408) 827-5745
Report post
Report user
Block user
commercialsearch

Exploring Redevelopment Opportunities Within Life Sciences

Exploring Redevelopment Opportunities Within Life Sciences

Experts discuss why and how adaptive reuse projects can alleviate current supply pressures.

The post Exploring Redevelopment Opportunities Within Life Sciences appeared first on Commercial Property Executive.

Exploring Redevelopment Opportunities Within Life Sciences
You can contact us to get more choices
0
You can contact us to get more choices
Related posts
Exploring Redevelopment Opportunities Within Life Sciences
Exploring Redevelopment Opportunities Within Life Sciences
Exploring Redevelopment Opportunities Within Life Sciences
Exploring Redevelopment Opportunities Within Life Sciences
commercialsearch commercialsearch | 1 year ago
Experts discuss why and how adaptive reuse projects can alleviate current supply pressures. The post Exploring Redevelopment Opportunities Within Life Sciences appeared first on Commercial Property Executive.
Experts discuss why and how adaptive reuse projects can alleviate current supply pressures. The post Exploring Redevelopment Opportunities Within Life Sciences appeared first on Commercial Property Executive.
Kier wins London life sciences job
Kier wins London life sciences job
Kier wins London life sciences job
Kier wins London life sciences job
Construction news, jobs and co... Construction news, j... | 1 year ago
The project known as the Refinery will create 121,000 sq ft of high spec, laboratory, research and development spaces under one roof. Located on the Northern Embankment of the River Thames, the project will include the extension and full reconfiguration of the existing four-storey building. Its façade and roof will be replaced, two new storeys added, and a green roof will finish the look of the building. During the project, Kier will support local small and medium enterprises (SMEs) through t...
The project known as the Refinery will create 121,000 sq ft of high spec, laboratory, research and development spaces under one roof. Located on the Northern Embankment of the River Thames, the project will include the extension and full reconfiguration of the existing four-storey building. Its façade and roof will be replaced, two new storeys added, and a green roof will finish the look of the building. During the project, Kier will support local small and medium enterprises (SMEs) through t...
£350m London Bridge life sciences hub advance
£350m London Bridge life sciences hub advance
£350m London Bridge life sciences hub advance
£350m London Bridge life sciences hub advance
Construction news, jobs and co... Construction news, j... | 1 year ago
Guy’s & St Thomas’ Foundation selects developer for Snowsfields Quarter biosciences hub
Guy’s & St Thomas’ Foundation selects developer for Snowsfields Quarter biosciences hub
Houston's Life Sciences Push - THE TENANT ADVISOR
Houston's Life Sciences Push - THE TENANT ADVISOR
Houston's Life Sciences Push - THE TENANT ADVISOR
Houston's Life Sciences Push - THE TENANT ADVISOR
coydavidson coydavidson | 1 year ago
Texas Medical Center Announces TMC BioPort campus The Texas Medical Center announced plans for a 4th campus a massive biomanufacturing and medical supplies distribution center in Houston. TMC BioPort will be built on 500 acres south of Loop 610. The newest campus is still in the early stages of development. However, once completed, it’s expected to double the overall size of the medical center and create 100,000 jobs for the Greater Houston metro, TMC President and CEO Bill McKeon said during ...
Texas Medical Center Announces TMC BioPort campus The Texas Medical Center announced plans for a 4th campus a massive biomanufacturing and medical supplies distribution center in Houston. TMC BioPort will be built on 500 acres south of Loop 610. The newest campus is still in the early stages of development. However, once completed, it’s expected to double the overall size of the medical center and create 100,000 jobs for the Greater Houston metro, TMC President and CEO Bill McKeon said during ...
CRE and the Life Sciences Boom
CRE and the Life Sciences Boom
CRE and the Life Sciences Boom
CRE and the Life Sciences Boom
kbs kbs | 1 year ago
Even before the pandemic, demand for life sciences had been building for almost 20 years. In 2020, pharma, R&D, and medical technology raced to procure vital medical products and solutions to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom. In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies, up from $70 billion the year prior. Key life science...
Even before the pandemic, demand for life sciences had been building for almost 20 years. In 2020, pharma, R&D, and medical technology raced to procure vital medical products and solutions to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom. In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies, up from $70 billion the year prior. Key life science...
Developers Look to Triple Greater Boston's Life Sciences Space
Developers Look to Triple Greater Boston's Life Sciences Space
Developers Look to Triple Greater Boston's Life Sciences Space
Developers Look to Triple Greater Boston's Life Sciences Space
Engineering News-Record Engineering News-Rec... | 1 year ago
Outlook highlighted ACEC's first private market symposium April 29 on health care and biotech R&D and manufacturing sectors
Outlook highlighted ACEC's first private market symposium April 29 on health care and biotech R&D and manufacturing sectors
BioMed Realty Pays $127M for Seattle Life Sciences Site
BioMed Realty Pays $127M for Seattle Life Sciences Site
BioMed Realty Pays $127M for Seattle Life Sciences Site
BioMed Realty Pays $127M for Seattle Life Sciences Site
commercialsearch commercialsearch | 2 years ago
Blackstone's subdivision will soon double its portfolio in the local market. The post BioMed Realty Pays $127M for Seattle Life Sciences Site appeared first on Commercial Property Executive.
Blackstone's subdivision will soon double its portfolio in the local market. The post BioMed Realty Pays $127M for Seattle Life Sciences Site appeared first on Commercial Property Executive.
Adaptive Reuse or New Construction? Considerations for Life Sciences
Adaptive Reuse or New Construction? Considerations for Life Sciences
Adaptive Reuse or New Construction? Considerations for Life Sciences
Adaptive Reuse or New Construction? Considerations for Life Sciences
commercialsearch commercialsearch | 2 years ago
Consider these factor when determining which direction to pursue, says Justin Brasell and David Klein of Transwestern. The post Adaptive Reuse or New Construction? Considerations for Life Sciences appeared first on Commercial Property Executive.
Consider these factor when determining which direction to pursue, says Justin Brasell and David Klein of Transwestern. The post Adaptive Reuse or New Construction? Considerations for Life Sciences appeared first on Commercial Property Executive.
Developers Look to Triple Greater Boston Area Life Sciences Space
Developers Look to Triple Greater Boston Area Life Sciences Space
Developers Look to Triple Greater Boston Area Life Sciences Space
Developers Look to Triple Greater Boston Area Life Sciences Space
Engineering News-Record Engineering News-Rec... | 1 year ago
Outlook highlighted ACEC's first private market symposium April 29 on health care and biotech R&D and manufacturing sectors
Outlook highlighted ACEC's first private market symposium April 29 on health care and biotech R&D and manufacturing sectors
After ‘Odd Year’ for Life Sciences, What’s Next?
After ‘Odd Year’ for Life Sciences, What’s Next?
After ‘Odd Year’ for Life Sciences, What’s Next?
After ‘Odd Year’ for Life Sciences, What’s Next?
propmodo propmodo | 1 year ago
In 2021, the life sciences sector had one of its best years on record. Already growing rapidly before the pandemic hit, the race to develop vaccines helped further bolster the niche sector, leading to a record number of IPOs formed last year. But 2022 has been different. The COVID-19 boost the industry benefited from has ended, and numbers are coming back down to Earth, looking more like they did pre-pandemic. Investment activity and venture capital funding have dropped significantly, and overal...
In 2021, the life sciences sector had one of its best years on record. Already growing rapidly before the pandemic hit, the race to develop vaccines helped further bolster the niche sector, leading to a record number of IPOs formed last year. But 2022 has been different. The COVID-19 boost the industry benefited from has ended, and numbers are coming back down to Earth, looking more like they did pre-pandemic. Investment activity and venture capital funding have dropped significantly, and overal...